• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    More On GENT

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Gentium S.p.A (GENT)

    -NasdaqGM
    55.04 Mar 7, 4:00PM EST
    Add to Portfolio
    Prev Close:55.04
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:78.00
    Beta:1.99
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:7.26 - 59.25
    Volume:0
    Avg Vol (3m):199,961
    Market Cap:N/A
    P/E (ttm):114.43
    EPS (ttm):0.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GENT 0.00%N/A
    BMY103.61B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (Dec-13) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gentium S.p.A., a biopharmaceutical company, engages in the research and development of drugs derived from DNA and DNA molecules. The company develops and manufactures defibrotide, an investigational drug based on a mixture of single-and double-st... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback